Your missing the whole development and supply chain part. It takes years to figure out the issues to go from bench scale to large scale. And that’s in industries where they’ve done this before.
Neither Moderna or BioNTech have ever made it to any large clinical trial before yet they can manufacture enough for the entire population 4x over.
They didn't do trials remember? They went straight to emergency production with concurrent trials. Therefore they didn't figure out the issues, hence why people are dropping like flies. I also assume production is outsourced as well - many countries have deals for local production. I think they also get to waive some liability. Robert Malone talks about waiting liability when outsourcing trials on the JRE podcast, so outsourcing production to more qualified and scalable organisations wouldn't be a huge mental leap.
Everything has been outsourced in pharmaceuticals already. That’s not new. You can just do a quick search for CROs and CDMOs (contract research/development/manufacturing organization). Fujifilm is one. What is new is mRNA technology.
The problem is all the protocols and procedures are either developed prior if they’re novel, or they’ve been used for decades (like formulating an api into a tablet or capsule). It takes significant time no matter the resources to work out the kinks. This never happened. Something is off.
Your missing the whole development and supply chain part. It takes years to figure out the issues to go from bench scale to large scale. And that’s in industries where they’ve done this before.
Neither Moderna or BioNTech have ever made it to any large clinical trial before yet they can manufacture enough for the entire population 4x over.
They didn't do trials remember? They went straight to emergency production with concurrent trials. Therefore they didn't figure out the issues, hence why people are dropping like flies. I also assume production is outsourced as well - many countries have deals for local production. I think they also get to waive some liability. Robert Malone talks about waiting liability when outsourcing trials on the JRE podcast, so outsourcing production to more qualified and scalable organisations wouldn't be a huge mental leap.
Everything has been outsourced in pharmaceuticals already. That’s not new. You can just do a quick search for CROs and CDMOs (contract research/development/manufacturing organization). Fujifilm is one. What is new is mRNA technology.
The problem is all the protocols and procedures are either developed prior if they’re novel, or they’ve been used for decades (like formulating an api into a tablet or capsule). It takes significant time no matter the resources to work out the kinks. This never happened. Something is off.